Company · CIK 0001404644 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Neurogene Inc. · NGNE
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 6, 2026 SForm 4 → | Jul 7, 9:08 pm EDT | Christine Mikail CvijicPresident and CFO, Director | 4,800 | $36.12 | $173,375 | 84,040 | −5.40% | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 2, 6:42 pm EDT | Christine Mikail CvijicPresident and CFO, Director | 4,800 | $34.71 | $166,586 | 88,840 | −5.13% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.